Economic analyses of respiratory syncytial virus immunoprophylaxis in high-risk infants: a systematic review.
about
Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in childrenPharmaceutical industry sponsorship and research outcome and quality: systematic reviewDevelopment of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genesEffectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World PerspectiveAdherence to Immunoprophylaxis Regimens for Respiratory Syncytial Virus Infection in Insured and Medicaid Populations.RNA virus reverse genetics and vaccine design.Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors.Influence of common non-synonymous Toll-like receptor 4 polymorphisms on bronchopulmonary dysplasia and prematurity in human infants.Low incidence of respiratory syncytial virus hospitalisations in haemodynamically significant congenital heart disease.Palivizumab for preterm infants. Is it worth it?An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in childrenCharacterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion GlycoproteinBlocking Respiratory Syncytial Virus Entry: A Story with Twists.Respiratory syncytial virus bronchiolitis.Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV)Prophylaxis of respiratory syncytial virus in Canada in 2003.Cost effectiveness of respiratory syncytial virus prophylaxis: a critical and systematic review.Predictors of severity and mortality in children hospitalized with respiratory syncytial virus infection in a tropical region.A review of palivizumab and emerging therapies for respiratory syncytial virus.Impact of palivizumab on RSV hospitalizations for children with hemodynamically significant congenital heart disease.Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis.Palivizumab in preventing respiratory syncytial virus-related hospitalization in high-risk infants.Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation.Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial VirusesEffectiveness of palivizumab prophylaxis in infants and children in Florida
P2860
Q24234622-0A7F4C3C-9114-4777-AE2D-4FBC1256544EQ24673248-0F4F5D9D-E9D2-4E5F-B633-9BCA988E1425Q26782411-FBE4A01A-A041-4DF3-A316-34E4E288562CQ26830864-75F44777-793C-4A27-91BE-F2CCEE452751Q33705088-6E5A228B-077C-43F8-AC4F-B38BA51AA975Q33963398-42A23A7C-4D75-4FF4-90E5-6C6A1A6B75B8Q34082711-DDC4D3DC-6C66-415F-86A7-34BE535D9D7EQ34163497-211E0F8C-BFAA-4166-BE64-DB2447C77A78Q35277282-EE27A01D-B284-4B9D-AD5A-66B1297561FDQ35296973-C7EEBCDB-26C4-4934-8013-0FC10EAB068DQ35595950-10B1981D-7594-4A55-9C25-FFFB3BB0D48CQ35687662-79D3506E-B8BF-4F09-9C15-8F1A097ECFFBQ35910907-D031F0BB-B3BD-4A95-92CC-27A299EC10E2Q36361899-20FB178C-6D01-427C-A9C6-1D9E83333C44Q37290618-80251BDC-A80C-4193-8599-7032C168A328Q37481321-7E52B181-2B6C-4723-812A-3C9165AC5CB0Q37687325-15DE6EC4-7D46-45BF-8ABA-A0B6C4E32C7EQ37727985-EC8EB69D-93C8-4021-9ADB-EB2D7811288EQ37914882-C2FF1399-2133-4FEC-8161-BCFD9B5A6968Q41778509-7CB0CE23-4628-4643-955D-7B770274F2F4Q42023014-94A6B787-C1EA-4098-84FF-5B89EE9B303BQ45375474-5C0DFCB2-95B5-4751-B649-89F091864C95Q49361412-743AB2B2-B5B5-4869-8F16-5FF2950B5CD2Q57095720-D2989280-C803-427F-8A56-693A8E813118Q57830092-DCC91A0B-D35D-4EBE-916F-08F870DC35D3
P2860
Economic analyses of respiratory syncytial virus immunoprophylaxis in high-risk infants: a systematic review.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Economic analyses of respirato ...... infants: a systematic review.
@ast
Economic analyses of respirato ...... infants: a systematic review.
@en
Economic analyses of respirato ...... infants: a systematic review.
@nl
type
label
Economic analyses of respirato ...... infants: a systematic review.
@ast
Economic analyses of respirato ...... infants: a systematic review.
@en
Economic analyses of respirato ...... infants: a systematic review.
@nl
prefLabel
Economic analyses of respirato ...... infants: a systematic review.
@ast
Economic analyses of respirato ...... infants: a systematic review.
@en
Economic analyses of respirato ...... infants: a systematic review.
@nl
P2093
P1433
P1476
Economic analyses of respirato ...... infants: a systematic review.
@en
P2093
Jalpa Doshi
James Campbell
Sachin Kamal-Bahl
P304
P356
10.1001/ARCHPEDI.156.10.1034
P407
P577
2002-10-01T00:00:00Z